Is IMF Bentham Ltd a buy?

Litigation funder IMF Bentham Ltd (ASX:IMF) is in a class of its own.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A class action is where individuals with common interests launch legal action against a company for an alleged wrong. Generally, class actions allow any "aggrieved persons" to join a matter and have their claim heard with every other individual that has a "substantially similar" claim ("the Class"). If the court rules in favour of the class, all individuals in that matter are entitled to a share of the proceeds. If the court rules against the class, all members of the case are liable for a portion of the cost of litigation and automatically waive their right to sue the wrongdoer.

The role of a litigation funder is to provide money for such class actions; litigation funding is a fickle business as the funder agrees to bear the cost of losing in return for a slice of the proceeds if the action is successful. IMF Bentham Ltd (ASX: IMF) is the biggest litigation funder in Australia, and the recent retreat in its share price presents a great opportunity to buy a growing business.

A strong track record

IMF started funding cases in Australia in 2002. It has been the financial backer of some of the largest class actions in Australia, including cases against the directors of ABC Learning, Forge Group, Treasury Wines Estates Ltd (ASX: TWE) and more recently, Australia and New Zealand Banking Group (ASX: ANZ) for its penalty fees on credit cards.

IMF agrees to take on cases and pay for the costs of litigation, on the condition that it receives a portion of the payout if the matter is successful. The business model is similar to a managed fund, given IMF needs to pick which cases it will fund.

The process requires meticulous case selection, which IMF has demonstrated over the years. To date, IMF has funded over 175 cases and has only lost 10 of them, indicating management's selective and level-headed approach is working.

A stable pipeline

As at 30 June 2015, IMF had $89.1 million in cash and a net tangible asset backing of $1.11 per share. The value of current cases was estimated to be worth $2.03 billion, with IMF's share being approximately $650 million over the next three years (if successful).

Although every case may not result in a win, IMF's strategy is driven by statistics as it assesses each case on its merits (based on potential payout and costs) and then selectively funds cases which provide a positive risk-weighted return. That is, IMF only 'invests' in cases where the legal probability of winning/settlement is higher than the cost of funding the matter (on a dollar-for-dollar basis). This stringent approach is how IMF averaged a return on investment of 158% during the 2015 financial year.

Accordingly, IMF's portfolio of cases is generally weighted to provide a positive return based on the expected payout of each case and thus any investment by IMF is, in the long term, likely to be accretive to earnings per share.

A solid income stream

Whilst earnings can be volatile in the short term, given the timing of case wins, IMF has resolved to provide an ongoing, semi-annual, fully-franked dividend of 5 cents per share. This represents a modest payout ratio of 40%, leaving the company well capitalised to fund new cases.

As current cases finalise, IMF expects the dividend to increase to 14 cents per share per annum in 2016, representing a forward yield of 9.3% if that eventuates.

Foolish takeaway

Despite the challenges involved in litigation funding, IMF Bentham appears to have mastered the business with a strong track record and solid pipeline of cases, making it, in my opinion, a buy at today's prices.

Motley Fool contributor Rachit Dudhwala owns shares in IMF Bentham. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »